AMCR Institute, Inc | Escondido, CA

Research site

(Unclaimed)

Location

625 West Citracado Parkway, #112, Escondido, California, United States of America

Site insights

Top conditions

Top treatments

Dasiglucagon

Orforglipron

Insulin aspart

Semaglutide

LY3502970

Triglycerides

Glucose

Nasulin

mifepristone

LY3209590

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 78 total trials

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight (REDEFINE 2)

This study will look at how well the new medicine CagriSema helps people living with excess body weight and type 2 diabetes losing weight. Participan...

Active, not recruiting

Overweight

Type 2 Diabetes Mellitus

Drug: Placebo semaglutide

Drug: Placebo cagrilintide

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1)

This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-rela...

Active, not recruiting

Overweight or Obesity

Overweight

Drug: Placebo

Drug: Orforglipron

A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)

This study will investigate the safety and efficacy of once daily oral treatment with orforglipron compared with placebo on body weight in adult part...

Active, not recruiting

Overweight

Obesity

Drug: Orforglipron

Drug: Placebo

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

The purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with dia...

Begins enrollment in 1 month

Type 1 Diabetes

Diabetes Mellitus

Device: RIGHTEST Continuous Glucose Monitoring System

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System with Enhanced Features. The purpose of this clinical investi...

Enrolling

Diabetes Mellitus, Type 1

Diabetes Mellitus

Device: Continuous Glucose Monitoring System